Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial.

von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H.

Ann Intern Med. 1999 Apr 6;130(7):554-62.

PMID:
10189324
2.

Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group.

Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC.

J Am Coll Cardiol. 1995 Jun;25(7):1492-8.

3.

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.

Arch Neurol. 2006 Oct;63(10):1402-8.

PMID:
17030655
4.

Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries.

Angerer P, Kothny W, Störk S, von Schacky C.

Cardiovasc Res. 2002 Apr;54(1):183-90.

5.

The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.

Cashin-Hemphill L, Kramsch DM, Azen SP, DeMets D, DeBoer LW, Hwang I, Vailas L, Hirsch LJ, Mack WJ, DeBoer L, et al.

Online J Curr Clin Trials. 1992 Oct 23;Doc No 26:[9897 words; 83 paragraphs]. Erratum in: Online J Curr Clin Trials 1992 Nov 14;Doc No 29:[85 words; 2.

PMID:
1343613
6.

Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease.

Erkkilä AT, Lichtenstein AH, Mozaffarian D, Herrington DM.

Am J Clin Nutr. 2004 Sep;80(3):626-32.

8.

Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.

Bowden RG, Jitomir J, Wilson RL, Gentile M.

J Ren Nutr. 2009 Jul;19(4):259-66. doi: 10.1053/j.jrn.2009.01.030.

PMID:
19539180
9.

Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial.

van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Hoefnagels WH, Beekman AT, de Groot LC.

Am J Clin Nutr. 2008 Sep;88(3):706-13.

10.

Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]).

Herd JA, Ballantyne CM, Farmer JA, Ferguson JJ 3rd, Jones PH, West MS, Gould KL, Gotto AM Jr.

Am J Cardiol. 1997 Aug 1;80(3):278-86.

PMID:
9264419
11.

Fish oil reduced heart disease in controlled trial.

[No authors listed]

AIDS Treat News. 1999 Apr 16;(No 317):3-4.

PMID:
11366995
12.
13.

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, DeBoer LW, Mahrer PR, Masteller MJ, Vailas LI, Alaupovic P, Hirsch LJ; MARS Research Group.

Ann Intern Med. 1993 Nov 15;119(10):969-76.

PMID:
8214993
14.

Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke: a randomized, controlled trial.

Poppitt SD, Howe CA, Lithander FE, Silvers KM, Lin RB, Croft J, Ratnasabapathy Y, Gibson RA, Anderson CS.

Stroke. 2009 Nov;40(11):3485-92. doi: 10.1161/STROKEAHA.109.555136. Epub 2009 Sep 10.

15.

Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.

Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.

Drugs R D. 2005;6(4):207-19.

PMID:
16050054
16.

Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.

Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE.

Pharmacotherapy. 2007 May;27(5):633-8.

PMID:
17461697
17.
18.
19.
Items per page

Supplemental Content

Write to the Help Desk